Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

2.770 +0.020 (+0.73%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ATAI Life Sciences N.V. - Common Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
28 29 Next >
Psychedelic Stock Gainers And Losers From December 19, 2022
Via Benzinga
atai Life Sciences Initiates Phase 2b proof-of-concept trial of RL-007 for Cognitive Impairment Associated with Schizophrenia
From atai Life Sciences
Via GlobeNewswire
Major Psychedelic Drug Stocks Down Another 7% This Week; Now Down 54% YTD
The 6 largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances are down again this week. 
Via Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort at Massachusetts General Hospital
From atai Life Sciences
Via GlobeNewswire
Psychedelic Stock Gainers And Losers From December 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From December 13, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From December 9, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From December 7, 2022
Via Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Part one of a three-part series. The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 12, 2022
Via Benzinga
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. 
Via Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 2, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From December 1, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022
Via Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
3 Big Trends Shaking Up Psychedelic Stocks
Major positive shifts are happening, but the field faces new headwinds too. 
Via The Motley Fool
atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer
From atai Life Sciences
Via GlobeNewswire
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From November 25, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
Via Benzinga
Tesla, Deere And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
(Part three of a four-part series) Have a look at previous stories: 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.